Invasive Candidiasis
Information
- Disease name
- Invasive Candidiasis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00189709 | Completed | Phase 3 | Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia | August 2004 | July 2006 |
| NCT00250432 | Completed | Phase 3 | A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) | January 2006 | March 2008 |
| NCT00520234 | Completed | Phase 4 | Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) | August 2007 | March 2010 |
| NCT00548262 | Completed | Phase 4 | This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis | February 2008 | October 2009 |
| NCT00607763 | Completed | Phase 1 | Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug | October 2007 | October 2009 |
| NCT00608335 | Completed | Phase 1 | Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug | October 14, 2007 | September 8, 2011 |
| NCT00670657 | Completed | Phase 4 | CRITIC - Treatment of Candidemia and Invasive Candidiasis | May 2007 | January 2009 |
| NCT00672841 | Completed | N/A | β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients | June 2008 | January 2011 |
| NCT00689338 | Completed | Phase 3 | Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study | July 2008 | May 2010 |
| NCT00786903 | Completed | Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen? | November 2008 | April 2015 | |
| NCT01716988 | Completed | Pharmacokinetics of Micafungin in Critically Ill Patients | October 2012 | January 2017 | |
| NCT01773876 | Completed | Phase 3 | Empirical Antifungal Treatment in ICUS | July 2012 | February 2015 |
| NCT02164890 | Completed | Phase 4 | Pharmacokinetics of Micafungin in Patients of Intensive Care Units | June 2014 | December 2016 |
| NCT02220790 | Completed | BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia | January 2015 | October 8, 2020 | |
| NCT02491151 | Completed | Variability of Fluconazole Concentration in Critically Ill Patients | October 2014 | December 2016 | |
| NCT02734862 | Completed | Phase 2 | CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension | July 26, 2016 | July 2019 |
| NCT02801682 | Completed | NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis | June 2016 | August 2021 | |
| NCT02841501 | Completed | Genetic Susceptibility Factors for Candidemia. | June 2013 | June 25, 2020 | |
| NCT03059992 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment | April 1, 2017 | August 17, 2023 |
| NCT05496725 | Completed | Phase 4 | Evaluate Bioequivalence of Micafungin (50mg/Vial) | January 6, 2022 | July 28, 2022 |
| NCT01047267 | Completed | Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) | June 2010 | December 2011 | |
| NCT01490684 | Completed | Invasive Candidiasis in Saudi ICUs | August 2012 | May 2016 | |
| NCT01666769 | Completed | Phase 1 | Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation | January 2013 | February 9, 2016 |
| NCT05707832 | Not yet recruiting | Phase 3 | A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus | March 30, 2023 | December 15, 2025 |
| NCT06456151 | Recruiting | Invasive Candidiasis in Critical Care | April 11, 2024 | December 2027 | |
| NCT03538912 | Recruiting | N/A | Early Discontinuation of Empirical Antifungal Therapy and Biomarkers | June 6, 2018 | June 2025 |
| NCT05763251 | Recruiting | N/A | Comparison of Uncomplicated Candidemia Therapy Duration in Children | September 8, 2023 | June 30, 2032 |
| NCT04368559 | Recruiting | Phase 3 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation | May 11, 2020 | August 2024 |
| NCT03906916 | Terminated | Phase 4 | Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin | July 18, 2018 | February 1, 2019 |
| NCT01213823 | Terminated | Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins | September 2008 | May 2011 | |
| NCT01045798 | Terminated | Phase 2 | Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) | December 2010 | April 2012 |
| NCT04225195 | Unknown status | Phase 2 | Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis | January 2020 | June 2022 |
| NCT01438216 | Unknown status | Anidulafungin Pharmacokinetics in Intensive Care Unit Patients | September 2011 | March 2012 |
- MedGen concept unique identifier (MedGen Concept name)
- C0153252
- MedGen unique identifier (MedGen Concept name)
- 102260